AGS-15ME

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGS-15ME, covering 2024-11-01 to 2024-11-01. Get the full timeline:

Most recent: Clinical Trial Update: ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer [Phase 1]

See pricing